217 related articles for article (PubMed ID: 33545550)
1. Effectiveness of oritavancin for management of skin and soft tissue infections in the emergency department: A case series.
Dretske D; Schulz L; Werner E; Sharp B; Pulia M
Am J Emerg Med; 2021 May; 43():77-80. PubMed ID: 33545550
[TBL] [Abstract][Full Text] [Related]
2. Finding the niche: An interprofessional approach to defining oritavancin use criteria in the emergency department.
Baxa J; McCreary E; Schulz L; Pulia M
Am J Emerg Med; 2020 Feb; 38(2):321-324. PubMed ID: 31839519
[TBL] [Abstract][Full Text] [Related]
3. Oritavancin versus oral antibiotics for treatment of skin and skin structure infections in the emergency department.
Sacdal JPA; Cheon E; Stilwell AM; Acquisto NM; Treu CN
Am J Emerg Med; 2022 Oct; 60():223-224. PubMed ID: 35835659
[No Abstract] [Full Text] [Related]
4. Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
Saddler K; Zhang J; Sul J; Patel P; Castro-Lainez M; Stevens ML; Kosler S; Lowery E; Sierra-Hoffman M
PLoS One; 2021; 16(3):e0248129. PubMed ID: 33735185
[TBL] [Abstract][Full Text] [Related]
5. Multiple-Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated Infections.
Schulz LT; Dworkin E; Dela-Pena J; Rose WE
Pharmacotherapy; 2018 Jan; 38(1):152-159. PubMed ID: 29121395
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin Use in Patients Discharged From the Emergency Department: A Retrospective Observational Cohort Study.
Mueller K; McCammon C; Skrupky L; Fuller BM
J Emerg Med; 2015 Jul; 49(1):50-7. PubMed ID: 25802166
[TBL] [Abstract][Full Text] [Related]
7. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
Chan M; Ooi CK; Wong J; Zhong L; Lye D
BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
[TBL] [Abstract][Full Text] [Related]
8. Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.
Corey GR; Good S; Jiang H; Moeck G; Wikler M; Green S; Manos P; Keech R; Singh R; Heller B; Bubnova N; O'Riordan W;
Clin Infect Dis; 2015 Jan; 60(2):254-62. PubMed ID: 25294250
[TBL] [Abstract][Full Text] [Related]
9. Impact of clinical decision support on oritavancin prescribing in the emergency department.
Treu CN; Cheon E; Wu G; Horowitz HW
J Am Pharm Assoc (2003); 2021; 61(2):169-173. PubMed ID: 33279426
[TBL] [Abstract][Full Text] [Related]
10. Emergency department management of cellulitis and other skin and soft-tissue infections.
Howarth K; Thoppil J; Salazar GA
Emerg Med Pract; 2022 May; 24(5):1-24. PubMed ID: 35467810
[TBL] [Abstract][Full Text] [Related]
11. Management of afebrile neonates with skin and soft tissue infections in the pediatric emergency department.
Kharazmi SA; Hirsh DA; Simon HK; Jain S
Pediatr Emerg Care; 2012 Oct; 28(10):1013-6. PubMed ID: 23023469
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Oral Antibiotic Treatment Failure for Nonpurulent Skin and Soft Tissue Infections in the Emergency Department.
Yadav K; Suh KN; Eagles D; MacIsaac J; Ritchie D; Bernick J; Thiruganasambandamoorthy V; Wells G; Stiell IG
Acad Emerg Med; 2019 Jan; 26(1):51-59. PubMed ID: 29869364
[TBL] [Abstract][Full Text] [Related]
13. Head-to-head comparison of multi-dose oritavancin and dalbavancin for complicated infections: A propensity score-matched analysis.
Steuber TD; Gipson H; Boyett B; Belk M; Thayer B; Edwards J
Int J Antimicrob Agents; 2024 Jun; 63(6):107165. PubMed ID: 38570019
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.
Yadav K; Suh KN; Eagles D; Thiruganasambandamoorthy V; Wells GA; Stiell IG
Am J Emerg Med; 2019 Nov; 37(11):2008-2014. PubMed ID: 30824277
[TBL] [Abstract][Full Text] [Related]
15. Evaluating an admission avoidance pathway for children in the emergency department: outpatient intravenous antibiotics for moderate/severe cellulitis.
Ibrahim LF; Hopper SM; Connell TG; Daley AJ; Bryant PA; Babl FE
Emerg Med J; 2017 Dec; 34(12):780-785. PubMed ID: 28978652
[TBL] [Abstract][Full Text] [Related]
16. Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis.
Agarwal R; Bartsch SM; Kelly BJ; Prewitt M; Liu Y; Chen Y; Umscheid CA
Clin Microbiol Infect; 2018 Apr; 24(4):361-368. PubMed ID: 28882727
[TBL] [Abstract][Full Text] [Related]
17. Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies.
Corey GR; Loutit J; Moeck G; Wikler M; Dudley MN; O'Riordan W;
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358292
[TBL] [Abstract][Full Text] [Related]
18. Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone.
Seaton RA; Bell E; Gourlay Y; Semple L
J Antimicrob Chemother; 2005 May; 55(5):764-7. PubMed ID: 15772137
[TBL] [Abstract][Full Text] [Related]
19. Beyond Vancomycin: The Tail of the Lipoglycopeptides.
Klinker KP; Borgert SJ
Clin Ther; 2015 Dec; 37(12):2619-36. PubMed ID: 26658277
[TBL] [Abstract][Full Text] [Related]
20. Non-purulent skin and soft tissue infections: predictive power of a severity score and the appropriateness of treatment in a prospective cohort.
Rath E; Skrede S; Oppegaard O; Bruun T
Infect Dis (Lond); 2020 May; 52(5):361-371. PubMed ID: 32052670
[No Abstract] [Full Text] [Related]
[Next] [New Search]
